TODAY'S NEWS
Previous studies have shown that men with low pros...
In a single-institution phase II study reported in...
A study using data from two major melanoma centers...
In a Chinese phase III trial reported in JAMA Onco...
In the first comparative clinical trial of lung ca...
More News From Today 
EDITORIALS & COMMENTARY
CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...
Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...
Diarrhea is often a presenting symptom in patients with neuroendocrine
tumors...
Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...
Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...
More Editorials & Commentary 
